首页> 外国专利> PHOTODYNAMIC THERAPY USING PHOTOSENSITIZING AGENT OR 5-AMINOLEVULINIC ACID

PHOTODYNAMIC THERAPY USING PHOTOSENSITIZING AGENT OR 5-AMINOLEVULINIC ACID

机译:用光敏剂或5-氨基戊酸进行光动力疗法

摘要

It is to provide photodynamic therapy (PDT) and photodynamic diagnosis (PDD) which are suitable for the diagnosis and therapy of a part requiring a certain degree of deep penetration, such as subcutaneous cancer and lymph nodes surrounded by blood vessels and fat. This is solved by performing PDT and PDD targeting cancer by administering a composition comprising a photosensitizing agent such as a tetrapyrrole-based compound (photofrin, protoporphyrin IX, etc.) or ALAs such as 5-aminolevulinic acid (ALA), ALA methyl ester, ALA ethyl ester, ALA propyl ester, ALA butyl ester, ALA pentyl ester, or a hydrochloride, phosphate, or sulfate thereof followed by irradiation with excitation light at a wavelength of 480 to 580 nm.
机译:提供光动力疗法(PDT)和光动力诊断(PDD),适用于需要一定深度渗透的部位的诊断和治疗,例如皮下癌和被血管和脂肪包围的淋巴结。通过施用包含光敏剂(例如基于四吡咯的化合物(光敏蛋白,原卟啉IX等)或ALA(例如5-氨基乙酰丙酸(ALA),ALA甲酯), ALA乙酯,ALA丙酯,ALA丁酯,ALA戊酯或其盐酸盐,磷酸盐或硫酸盐,然后用波长为480至580 nm的激发光照射。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号